Zobrazeno 1 - 2
of 2
pro vyhledávání: '"J Cheryian"'
Autor:
PM Calverley, K Maki-Petaja, CM McEniery, D Mohan, Charlotte E. Bolton, Lewis F Buss, Tricia M. McKeever, R Tal-Singer, M Polkey, R Siraj, W MacNee, J Forman, JR Cockcroft, IB Wilkinson, N Gale, J Cheryian, B Miller
Publikováno v:
Cellular insights into lung injury repair.
Background Advanced glycation endproducts (AGE) in patients with chronic obstructive pulmonary disease (COPD) has been considered in the pathology of the disease and as a biomarker of emphysema severity. In addition, AGE has been implicated in cardio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::380cbac37d986d9f57a5544f648f870e
https://doi.org/10.1136/thoraxjnl-2017-210983.199
https://doi.org/10.1136/thoraxjnl-2017-210983.199
Autor:
Kaisa M. Mäki-Petäjä, William MacNee, Charlotte E. Bolton, R Tal-Singer, J Cheryian, Tricia M. McKeever, Lewis F Buss, Julia R. Forman, Pma Calverley, Divya Mohan, Ian B. Wilkinson, John R. Cockcroft, Nichola S. Gale, Michael I. Polkey, Carmel M. McEniery
Publikováno v:
Multi-morbidity in COPD.
Introduction Blood eosinophils level in Chronic Obstructive Pulmonary Disease (COPD) is a candidate biomarker for Regulatory qualification as a drug development tool identifying individuals who may benefit from targeted therapies. Current evidence fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c0c770dd3acd0b8ca973096642c8531
https://doi.org/10.1136/thoraxjnl-2017-210983.236
https://doi.org/10.1136/thoraxjnl-2017-210983.236